Sales decline 26.30% to Rs 10.48 crore
Net loss of Bharat Immunological & Biological Corporation reported to Rs 5.00 crore in the quarter ended June 2022 as against net profit of Rs 1.93 crore during the previous quarter ended June 2021. Sales declined 26.30% to Rs 10.48 crore in the quarter ended June 2022 as against Rs 14.22 crore during the previous quarter ended June 2021. ParticularsQuarter EndedJun. 2022Jun. 2021% Var.Sales10.4814.22 -26 OPM %-46.097.38 -PBDT-6.270.14 PL PBT-6.310.08 PL NP-5.001.93 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
